Buy MERIONAL (hMG) 150 IU Online

Description

About MERIONAL 150 IU: MERIONAL 150 IU, manufactured by IBSA, is a pharmaceutical preparation containing Human Menopausal Gonadotropin (hMG) as its active substance. It is widely used in assisted reproductive technology (ART) protocols to stimulate ovulation in women undergoing infertility treatment. Human Menopausal Gonadotropin is a hormone extracted from the urine of postmenopausal women and contains a mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for the development and maturation of ovarian follicles.

Key Features:

• Ovulation Induction: MERIONAL 150 IU is used to stimulate ovulation in women with ovulatory disorders or those undergoing controlled ovarian stimulation for in vitro fertilization (IVF) or other assisted reproductive procedures.
• Human Menopausal Gonadotropin: Each ampule of MERIONAL 150 IU contains 150 international units (IU) of Human Menopausal Gonadotropin, ensuring precise dosing for ovulation induction protocols.
• Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH): The FSH and LH components in MERIONAL work synergistically to promote the growth and development of ovarian follicles, which are necessary for ovulation and fertility.
• Manufactured by IBSA: MERIONAL 150 IU is manufactured by IBSA, a reputable pharmaceutical company known for its expertise in reproductive medicine and women’s health.
• Clinically Proven Efficacy: The efficacy and safety of MERIONAL 150 IU have been demonstrated in clinical studies, making it a trusted choice for infertility treatment in women.
• Single Ampule Packaging: Each ampule of MERIONAL 150 IU is individually packaged, ensuring sterility and convenience in preparation and administration.

Indications: MERIONAL 150 IU (Human Menopausal Gonadotropin) is indicated for:

• Ovulation induction in women with ovulatory disorders, including anovulation and oligo-ovulation.
• Controlled ovarian stimulation for assisted reproductive technologies such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).

Usage Directions: MERIONAL 150 IU should be administered under the supervision of a qualified reproductive endocrinologist or fertility specialist experienced in ovulation induction protocols. The dosage and duration of treatment may vary depending on individual patient factors, including age, ovarian reserve, and response to therapy. Treatment with MERIONAL 150 IU typically involves daily injections for several days, with close monitoring of ovarian response through ultrasound and hormone measurements.

Storage Information:

• Store MERIONAL 150 IU ampules in the original packaging at controlled room temperature (20°C to 25°C).
• Protect from light and moisture.
• Do not freeze.
• Keep out of reach of children.

Caution:

• MERIONAL 150 IU should not be used in pregnant women or women with primary ovarian failure.
• Ovarian hyperstimulation syndrome (OHSS) and multiple gestation may occur with the use of MERIONAL 150 IU. Patients should be monitored closely for signs of ovarian hyperstimulation and multiple pregnancy during treatment.
• Use of MERIONAL 150 IU may increase the risk of ectopic pregnancy and ovarian torsion.

Disclaimer: The information provided herein is for informational purposes only and should not be construed as medical advice or a substitute for professional medical consultation. Patients should consult their healthcare providers regarding diagnosis, treatment, and potential side effects associated with MERIONAL 150 IU therapy.